Encompass Health Corporation $EHC Shares Sold by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. lessened its stake in shares of Encompass Health Corporation (NYSE:EHC) by 76.4% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 12,075 shares of the company’s stock after selling 39,062 shares during the period. Harbor Capital Advisors Inc.’s holdings in Encompass Health were worth $1,534,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Belpointe Asset Management LLC acquired a new stake in shares of Encompass Health during the 2nd quarter worth approximately $210,000. Marshall Wace LLP acquired a new stake in Encompass Health during the second quarter worth $34,719,000. Bahl & Gaynor Inc. raised its position in Encompass Health by 14.8% in the second quarter. Bahl & Gaynor Inc. now owns 288,226 shares of the company’s stock valued at $35,345,000 after purchasing an additional 37,161 shares during the period. Intech Investment Management LLC lifted its stake in shares of Encompass Health by 21.8% in the 1st quarter. Intech Investment Management LLC now owns 21,329 shares of the company’s stock valued at $2,160,000 after purchasing an additional 3,815 shares during the last quarter. Finally, Park Avenue Securities LLC increased its position in shares of Encompass Health by 28.5% during the 2nd quarter. Park Avenue Securities LLC now owns 9,153 shares of the company’s stock worth $1,122,000 after purchasing an additional 2,030 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Up 0.5%

EHC stock opened at $107.61 on Friday. The company’s 50 day moving average price is $114.32 and its 200 day moving average price is $117.95. The firm has a market capitalization of $10.83 billion, a price-to-earnings ratio of 20.34, a PEG ratio of 1.89 and a beta of 0.73. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.14.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The company had revenue of $136.30 million for the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, equities research analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Friday, January 2nd. Encompass Health’s payout ratio is 14.37%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Barclays increased their target price on shares of Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research note on Thursday, October 30th. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. UBS Group boosted their price objective on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Thursday, October 2nd. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, November 23rd. Finally, Bank of America boosted their price target on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $142.86.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.